Company news

908 Devices Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

908 Devices to Report Second Quarter 2024 Financial Results on August 6, 2024

July 22, 2024

908 Devices Appoints Michele M. Leonhart, Former Administrator of the United States Drug Enforcement Administration (DEA), to Its Board of Directors

June 24, 2024

908 Devices Enhances XplorIR Portable Analyzer to Simultaneously Identify and Quantify Hazardous Gases and Vapors

June 17, 2024

908 Devices Reports First Quarter 2024 Financial Results and Updates 2024 Revenue Outlook

April 29, 2024

908 Devices Acquires RedWave Technology, Expanding its Forensics Product Offering

April 29, 2024

908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024

April 22, 2024

908 Devices Trace Chemical Identification Technology Adopted by European Agencies

March 11, 2024

908 Devices Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Revenue Outlook

March 4, 2024

908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares’ Fully Integrated Cell Therapy Manufacturing Platform

February 28, 2024

908 Devices to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024

February 19, 2024

908 Devices Announces MX908 Integration Capabilities

November 13, 2023

908 Devices Reports Third Quarter 2023 Financial Results and Narrows 2023 Revenue Outlook

November 6, 2023

908 Devices and Terumo Blood and Cell Technologies Collaborate to Add On-line Analytics to Quantum Flex Cell Expansion System

November 5, 2023

908 Devices to Report Third Quarter Financial Results on November 7, 2023

October 23, 2023

908 Devices Awarded $10.4M Order from the United States Air Force for its Handheld MX908 Device

October 23, 2023

908 Devices Enters Initial Production Phase of US Department of Defense Aerosol and Vapor Chemical Agent Detector Program

September 25, 2023

908 Devices Launches MAVERICK for Real-Time In-Line Monitoring of Multiple Bioprocess Parameters

September 17, 2023

908 Devices to Participate in the Gilmartin Group Emerging Growth Company Showcase

September 14, 2023

908 Devices Reports Second Quarter 2023 Financial Results and Updates 2023 Revenue Outlook

August 7, 2023

908 Devices Partners with Tennessee State and Local Agencies in the Fight Against Drug Trafficking Through a New Pilot Program

August 6, 2023

908 Devices Launches Remote and Continuous Area Monitoring for Aerosol and Vapor Detection

July 30, 2023

908 Devices to Report Second Quarter Financial Results on August 8, 2023

July 24, 2023

908 Devices Features its High-Speed, High-Resolution Separations Technology at the 71st ASMS Conference

May 29, 2023

908 Devices to Participate in the William Blair 43rd Annual Growth Stock Conference

May 22, 2023

908 Devices Reports First Quarter 2023 Financial Results and Reiterates 2023 Revenue Outlook

May 8, 2023

908 Devices Launches Data Analysis Visualization Tool for REBEL At-line Cell Culture Media Analyzer

May 3, 2023

908 Devices to Report First Quarter Financial Results on May 9, 2023

April 24, 2023

908 Devices Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Revenue Outlook

March 6, 2023

908 Devices to Participate in the Cowen 43rd Annual Healthcare Conference

February 20, 2023

908 Devices to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023

February 13, 2023

908 Devices Unveils New Glucose and Lactate On-Line Device for Bioprocess Monitoring and Control

January 16, 2023

MX908 Device Enables Correctional Facility Personnel to Quickly Identify Illegal Drugs in Incoming Mail

December 6, 2022

908 Devices Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Outlook

November 13, 2022

908 Devices Records Strong Momentum in Life Sciences Sector

November 9, 2022

908 Devices Launches Pesticide Identification Capability to Thwart Illegal Marijuana Growing Operations

November 8, 2022

908 Devices to Report Third Quarter 2022 Financial Results on November 14, 2022

October 18, 2022

908 Devices and CPI Improve mAbs Cell Culture Outcomes Using At-line Media Analysis

October 11, 2022

908 Devices Reports Second Quarter 2022 Financial Results and Reiterates 2022 Revenue Outlook

August 8, 2022

908 Devices Acquires TRACE Analytics, Enabling On-line Bioanalytics

August 8, 2022

908 Devices to Participate in the Canaccord Genuity 42nd Annual Growth Conference

July 26, 2022

908 Devices to Report Second Quarter 2022 Financial Results on August 9, 2022

July 18, 2022

908 Devices Showcases Technology for Accelerating Mass Spec Workflows in Presentations at ASMS

June 1, 2022

908 Devices to Participate in the William Blair 42nd Annual Growth Stock Conference

May 25, 2022

908 Devices Reports First Quarter 2022 Financial Results and Reiterates 2022 Revenue Outlook

May 9, 2022

908 Devices Advances MX908 Handheld Device Capabilities

May 8, 2022

908 Devices Partners with Key Biomanufacturing Innovation Center

May 2, 2022

908 Devices and CPI Team on Cell Culture Media Optimization for Improved Process Control in Bioprocessing Applications

April 20, 2022

908 Devices to Report First Quarter Financial Results on May 10, 2022

April 11, 2022

908 Devices Reports Fourth Quarter and Full Year 2021 Financial Results and Provides 2022 Revenue Outlook

March 6, 2022

908 Devices Appoints Tony J. Hunt, President and CEO, Repligen, to its Board of Directors

March 1, 2022

← Newer news releases · Older news releases →

Calls

The 5 newest of 21 calls. Every call is listed under its year.

Decks

The 5 newest of 14 decks. Every deck is listed under its year.